Background Data on carcinogenicity of human papillomavirus (HPV) types in the anus are
needed to inform anal cancer prevention through vaccination and screening. This is …

Cancer is the second leading cause of death worldwide, and it is estimated that Human
papillomavirus (HPV) related cancers account for 5% of all human cancers. Current HPV …

There is limited access to effective cervical cancer screening programs in many resource‐
limited settings, resulting in continued high cervical cancer burden. Human papillomavirus …

Cervical cancer disproportionately affects women of reproductive age, with 80% of cases
occurring in low-and middle-income countries. Persistent infection with high-risk human …

Anal cancer incidence and mortality have been increasing over the past decade. Although
the incidence in the general population remains low, it is much higher in certain subgroups …

Cervical cancer is the first identified human papillomavirus (HPV) associated cancer and the
most promising malignancy to be eliminated. However, the ever-changing virus subtypes …

Background Anal human papillomavirus (HPV) infection, most notably HPV16, the central
cause of anal cancer, is increased by anal sexual intercourse and worsened by human …

Human papillomavirus (HPV) infection is responsible for approximately 5% of all cancers
and is associated with 30% of all pathogen-related cancers. Cervical cancer is the third most …

OBJECTIVES This review assessed the rate of high-risk human papillomavirus (HPV)
infection among women living in sub-Saharan Africa. It also determined the prevalence of …

Cervical cancer is the fourth most common malignancy in women worldwide and a leading
cause of cancer-related mortality in developing countries. Important etiological factors in this …